Paper41543641
Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction.
Huse C and 8 others. Curr Atheroscler Rep, 2026. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction. Papers, record 41543641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41543641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Infarction | Major topic |
| Interleukin-6 | Major topic |
| Atherosclerosis | Major topic |
| Thrombosis | Major topic |
| Humans | |
| Inflammation | |
| Receptors, Interleukin-6 | |
| Animals | |
| Interleukin-6 Inhibitors | |
| Antibodies, Monoclonal, Humanized | |
| Signal Transduction |
Source PubMed
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31327478 | Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype. | Atherosclerosis | 2019 | https://conductscience.org/library/papers/31327478 | PubMed |
| 2 | 39015380 | Myeloid-specific interleukin-6 response: from vascular effects to the potential for novel personalized medicines. | Eur Heart J Open | 2024 | https://conductscience.org/library/papers/39015380 | PubMed |
| 3 | 16996873 | Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease. | Am J Cardiol | 2006 | https://conductscience.org/library/papers/16996873 | PubMed |
| 4 | 33858620 | Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. | J Am Coll Cardiol | 2021 | https://conductscience.org/library/papers/33858620 | PubMed |
| 5 | 2310829 | Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. | Blood | 1990 | https://conductscience.org/library/papers/2310829 | PubMed |
| 6 | 40011978 | Inhibition of IL-6 trans-signaling promotes post-stroke functional recovery in a sex and dose-dependent manner. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40011978 | PubMed |
| 7 | 34102669 | Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction. | JACC Basic Transl Sci | 2021 | https://conductscience.org/library/papers/34102669 | PubMed |
| 8 | 31114509 | The JAK/STAT Pathway in Skeletal Muscle Pathophysiology. | Front Physiol | 2019 | https://conductscience.org/library/papers/31114509 | PubMed |
| 9 | 39910039 | Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow. | Nat Commun | 2025 | https://conductscience.org/library/papers/39910039 | PubMed |
| 10 | 34969940 | Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies. | Neurology | 2022 | https://conductscience.org/library/papers/34969940 | PubMed |
| 11 | 35402550 | The Role of Interleukin-6 Family Members in Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35402550 | PubMed |
| 12 | 30995492 | Targeting Interleukin-6 Signaling in Clinic. | Immunity | 2019 | https://conductscience.org/library/papers/30995492 | PubMed |
| 13 | 31543877 | Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. | Front Immunol | 2019 | https://conductscience.org/library/papers/31543877 | PubMed |
| 14 | 30165610 | Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). | Eur Heart J | 2018 | https://conductscience.org/library/papers/30165610 | PubMed |
| 15 | 27893700 | Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. | Nat Immunol | 2017 | https://conductscience.org/library/papers/27893700 | PubMed |
| 16 | 35949328 | IL-6 inhibitors effectively reverse post-infarction cardiac injury and ischemic myocardial remodeling via the TGF-β1/Smad3 signaling pathway. | Exp Ther Med | 2022 | https://conductscience.org/library/papers/35949328 | PubMed |
| 17 | 11121117 | Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. | Eur J Biochem | 2001 | https://conductscience.org/library/papers/11121117 | PubMed |
| 18 | 36090222 | Meta-analysis reveals inhibition of the inflammatory cytokine IL-6 affords limited protection post-myocardial ischemia/infarction. | Heliyon | 2022 | https://conductscience.org/library/papers/36090222 | PubMed |
| 19 | 24896536 | IL-6 strikes a balance in metabolic inflammation. | Cell Metab | 2014 | https://conductscience.org/library/papers/24896536 | PubMed |
| 20 | 12591746 | Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. | Circulation | 2003 | https://conductscience.org/library/papers/12591746 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942180 | Coronary and Peripheral Venous Inflammatory Biomarkers in Acute Myocardial Infarction: Associations with Myocardial Injury, Cardiac Function, and Clinical Outcomes. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942180 | PubMed |
| 42861282 | Adipocytokines as Pathogenic Mediators and Therapeutic Targets in Metabolic Syndrome-Related Cardiocerebrovascular Events. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/42861282 | PubMed |
| 42450316 | Cross-Species Identification and Validation of Hub Genes and Potential Therapeutic Targets in Myocardial Infarction. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450316 | PubMed |
| 42450168 | Immunothrombotic Cell-Cell Communication Networks in Coronary Atherosclerosis: Critical Insights from Single-Cell and Spatial Systems Biology. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450168 | PubMed |
| 42440441 | Bisphenols-enhanced platelet aggregation via TP, P2Y12, PAR1 and PAR4 receptors: a thrombotic legacy in a plastic-ubiquitous world. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42440441 | PubMed |
| 42416749 | The Impact of Interleukin-6 on the Severity of Coronary Artery Disease and the Prognosis of Patients with Acute Coronary Syndrome. | Maedica (Bucur) | 2026 | https://conductscience.org/library/papers/42416749 | PubMed |
| 42310735 | Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction. | J Transl Med | 2026 | https://conductscience.org/library/papers/42310735 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41543641
GET https://conductscience.org/api/papers/v1/41543641/references?page=2